阿拉伯心血管疾病患者的药物依从率：系统评价。
Medication Adherence Rate in Arab Patients With Cardiovascular Disease: A Systematic Review.
机构信息
Hamad Medical Corporation, Doha, Qatar.
University of Wollongong, Liverpool, New South Wales, Australia.
出版信息
J Transcult Nurs. 2022 Sep;33(5):632-641. doi: 10.1177/10436596221095851. Epub 2022 May 18.
BACKGROUND
Cardiovascular disease (CVD) is one of the most common chronic illnesses in the Eastern Mediterranean. There have been few studies on medication adherence in Arab patients with CVD.
AIM
To investigate the rates and the reasons for medication adherence in Arab patients with CVD.
METHODOLOGY
The Joanna Briggs Institute methodology for prevalence systematic reviews was used. MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, PsychINFO, and the Cochrane Central Register of Controlled Trials were searched.
RESULTS
Thirteen quantitative studies on medication adherence in Arab adult CVD patients were included.Pooled data from nine studies demonstrated that 53.2% (95% confidence interval = [51.2%, 55.1%]) of patients were adherent to their medications. Reasons for nonadherence to medication include personal factors, understanding, and complexity of treatment regimes, medication knowledge and structural barriers.
CONCLUSION
Medication adherence appears to have a social gradient, and families should be actively involved in future strategies to increase medication adherence.
背景
心血管疾病（CVD）是东地中海地区最常见的慢性病之一。针对阿拉伯 CVD 患者的药物依从性，相关研究较少。
目的
调查阿拉伯 CVD 患者的药物依从率及其原因。
方法
采用 Joanna Briggs 循证卫生保健中心的系统评价方法。检索了 MEDLINE、EMCARE、CINAHL、Scopus、Science Direct、PsychINFO 和 Cochrane 对照试验中心注册库。
结果
纳入了 13 项关于阿拉伯成年 CVD 患者药物依从性的定量研究。9 项研究的汇总数据表明，53.2%（95%置信区间=[51.2%，55.1%]）的患者依从药物治疗。不依从药物治疗的原因包括个人因素、对治疗方案的理解和复杂性、药物知识和结构障碍。
结论
药物依从性似乎存在社会梯度，未来的策略应积极调动家庭参与，以提高药物依从性。
Zotero 插件